clinical trial | Q30612 |
P3098 | ClinicalTrials.gov ID | NCT00865410 |
P6099 | clinical trial phase | phase I clinical trial | Q5452194 |
P17 | country | United States of America | Q30 |
P582 | end time | 2004-09-01 | |
P4135 | maximum age | 45 | |
P2899 | minimum age | 18 | |
P1132 | number of participants | 26 | |
P4844 | research intervention | bupropion | Q834280 |
P8005 | research subject recruitment status | completed | Q76651189 |
P580 | start time | 2004-08-01 | |
P8363 | study type | interventional study | Q78089383 |
P1476 | title | A Randomized, Single Dose Two -Way Crossover Relative Bioavailability Study of Bupropion Extended-Released Tablets Formulation in Fasted, Normal, Healthy Subjects. |